$75.00
TB-500, a synthetic version of the naturally occurring protein Thymosin Beta-4, is a 43-amino acid peptide with remarkable regenerative potential. It is well-studied for its role in tissue repair. It may enhance recovery and reduce inflammation and oxidative stress. This effect occurs in various body systems, including the nervous and cardiovascular systems.
TB-500 is a synthetic form of Thymosin Beta-4. This peptide consists of 43 amino acids and is found in almost all mammalian cells. It has become a focal point in regenerative biology for its reported ability to support tissue repair, angiogenesis, and cellular protection. Laboratory research explores its effects across neurological, cardiovascular, and musculoskeletal systems, making it one of the most versatile peptides in modern biomedical studies.
Thymosin Beta-4 was first found in the thymus gland. It was later identified in the body as an important regulator of cell structure and movement. Its synthetic analog, TB-500, enables standardized, reproducible research into tissue healing, wound recovery, and inflammation control. Research indicates that TB-500 mainly works by interacting with G-actin. This monomeric form of actin is essential for cell repair and movement.
The main mechanism of TB-500 is its binding affinity to actin. Actin is a protein that controls cell structure, migration, and differentiation. Through actin modulation, TB-500 may facilitate:
These mechanisms make TB-500 an essential tool for laboratories studying wound healing, cardiac tissue regeneration, neuroprotection, and vascular repair.
In preclinical models, TB-500 has shown neuroprotective effects. It supports glial and endothelial cells in the brain and spinal cord. These findings have prompted further exploration into its role in neuronal survival, myelination, and post-injury recovery. TB-500 is of particular interest to researchers investigating neuroregeneration following trauma or ischemic events.
Angiogenesis—the formation of new blood vessels—is a hallmark of effective tissue regeneration. TB-500 is reported to enhance VEGF expression and facilitate capillary sprouting within damaged or ischemic tissue. This mechanism contributes to studies on tissue oxygenation, post-surgical wound recovery, and cardiovascular adaptation.
Cardiac peptide research has highlighted TB-500’s influence on cell survival and fibrosis reduction following myocardial injury. In vitro and animal studies indicate that it may aid cardiomyocyte regeneration and reduce scar formation through extracellular matrix remodeling. These attributes make it a recurring focus in heart tissue bioengineering and regenerative medicine research models.
When combined with antibiotics such as ciprofloxacin, TB-500 has been shown to improve healing outcomes in infected tissue models. Research indicates that it may enhance antimicrobial efficacy by modulating immune response and accelerating re-epithelialization, particularly in wound or ulcer recovery studies.
Laboratory data show a connection between Thymosin Beta-4 levels and hair follicle regeneration. Animal models have reported increased follicular density and improved keratinocyte activity, leading to expanded research on dermal regeneration and alopecia pathways.
Early studies point to TB-500’s potential influence on autophagy, the body’s natural cellular cleanup mechanism. The compound is being studied for its role in clearing damaged proteins. Research focuses on models related to Alzheimer’s disease, prion disorders, and cellular senescence. Researchers are exploring how this process may contribute to improved cellular resilience and longevity.
TB-500 has structural and anti-inflammatory properties. These features make it a widely studied compound for musculoskeletal recovery and connective tissue repair. It promotes fibroblast migration and collagen synthesis, both of which are essential in skin, tendon, and ligament regeneration research.
At Amino Pharm, each vial of TB-500 (Thymosin Beta-4) is accompanied by a Certificate of Analysis (COA) verifying purity, sequence integrity, and molecular identity. Testing standards include:
What is TB-500 used for in research?
TB-500 is studied for its potential in tissue repair, actin modulation, angiogenesis, and cellular regeneration across neurological, cardiac, and musculoskeletal systems.
Does TB-500 influence growth factors?
Yes. Laboratory studies suggest it may increase VEGF and related growth factors that regulate vascular remodeling and wound recovery.
Can TB-500 be used in neurodegenerative research?
Yes, it is often examined in models exploring neuronal repair and protein clearance mechanisms such as autophagy.
How does TB-500 differ from natural Thymosin Beta-4?
TB-500 is a synthetic analog offering precise purity and repeatability, ideal for controlled scientific experimentation and reproducibility.
Where can researchers obtain TB-500?
Amino Pharm provides COA-verified research peptides manufactured in the U.S. under regulated laboratory standards. Visit AminoPharm.com for details.
⚠ FOR RESEARCH USE ONLY — NOT FOR HUMAN OR ANIMAL CONSUMPTION
This peptide is supplied exclusively for scientific and educational purposes. It is not approved for therapeutic, diagnostic, or clinical applications. By ordering, the purchaser confirms use is restricted to authorized laboratory research performed by qualified professionals.
TB-500 (Thymosin Beta-4) represents a foundational peptide in regenerative, cardiovascular, and neurorepair research. By interacting with actin and promoting vascular growth, it provides scientists with a reproducible model for studying cell migration, wound recovery, and angiogenesis. Each Amino Pharm batch is COA-verified, batch-tested, and traceable. This ensures reliability and precision for advanced peptide research.
